Skip directly to site content Skip directly to search
U.S. flag An official website of the United States government

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Viral Hemorrhagic Fever (VHF)
2010 Case Definition

Viral Hemorrhagic Fever (VHF)
2010 Case Definition
Print
NOTE: A surveillance case definition is a set of uniform criteria used to define a disease for public health surveillance. Surveillance case definitions enable public health officials to classify and count cases consistently across reporting jurisdictions. Surveillance case definitions are not intended to be used by healthcare providers for making a clinical diagnosis or determining how to meet an individual patient’s health needs.

CSTE Position Statement(s)

  • 09-ID-18

Subtype(s)

  • Crimean-Congo hemorrhagic fever virus
  • Ebola virus
  • Lassa virus
  • Marburg virus
  • New World arenavirus – Guanarito virus
  • New World arenavirus – Junin virus
  • New World arenavirus – Machupo virus
  • New World arenavirus – Sabia virus

Background

New world Arenaviruses include: Guanarito, Machupo, Junin, and Sabia.

Clinical Description

A person with acute onset with ALL the following clinical findings:

  • A fever >40°C, AND
  • One or more of the following clinical findings:
    • Severe headache
    • Muscle pain
    • Erythematous maculopapular rash on the trunk with fine desquamation 3–4 days after rash onset
    • Vomiting
    • Diarrhea
    • Pharyngitis (arenavirus only)
    • Abdominal pain
    • Bleeding not related to injury
    • Retrosternal chest pain (arenavirus only)
    • Proteinuria (arenavirus only)

Laboratory Criteria For Diagnosis

One or more of the following laboratory findings:

  • Detection of viral hemorrhagic fever (VHF) viral antigens in blood by enzyme-linked immunosorbent assay (ELISA) antigen detection
  • VHF viral isolation in cell culture for blood or tissues
  • Detection of VHF viral genes using reverse transcriptase with polymerase chain reaction amplification (RT-PCR) from blood or tissues
  • Detection of VHF viral antigens in tissues by immunohistochemistry

Exposure

  • One or more of the following exposures within the 3 weeks before onset of symptoms:
    • Contact with blood or other body fluids of a patient with VHF
    • Residence in—or travel to—a VHF endemic area
    • Work in a laboratory that handles VHF specimens
    • Work in a laboratory that handles primates from endemic areas

OR

  • Exposure within the past 3 weeks to semen from a confirmed acute or convalescent case of VHF within the 10 weeks of onset of symptoms

Case Classification

Suspected

Case meets the clinical and epidemiologic linkage criteria.

Confirmed

Case meets the clinical and laboratory criteria.

Related Case Definition(s)

Top of Page
Last Reviewed: April 16, 2021
Source: Office of Public Health Data, Surveillance, and Technology